A phase I microplaque study of XCUR17 in patients with mild to moderate psoriasis
Phase of Trial: Phase I
Latest Information Update: 15 May 2018
At a glance
- Drugs XCUR 17 (Primary)
- Indications Psoriasis
- Focus Adverse reactions
- 15 May 2018 According to an Exicure media release, company began dosing patients in early April 2018 and trial data is expected during the third quarter of this year.
- 15 May 2018 Status changed from planning to recruiting, according to an Exicure media release.
- 15 Mar 2018 New trial record